Talampanel
From Self-sufficiency
Revision as of 10:19, 27 August 2010 by حسن علي البط (Talk) (Removed Category:Benzodiazepines; Adding category Category:Dioxolobenzodiazepines (using HotCat))
File:Talampanel skeletal.svg | |
Systematic (IUPAC) name | |
---|---|
(8R)-7-Acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h] [2,3]benzodiazepine | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 161832-65-1 |
ATC code | none |
PubChem | CID 164509 |
Chemical data | |
Formula | C19H19N3O3 |
Molar mass | 337.372 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Talampanel (GYKI 53405) is a drug which is being investigated for the treatment of epilepsy[1], malignant gliomas[2] and amyotrophic lateral sclerosis (ALS)[3].
It is a noncompetitive antagonist of the AMPA receptor, a type of glutamate receptor in the central nervous system.[4]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
40px | This anticonvulsant-related article is a stub. You can help ssf by expanding it. |
- ↑ Luszczki, JJ (2009). "Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions". Pharmacological reports : PR. 61 (2): 197–216. PMID 19443931.
- ↑ Iwamoto, F. M.; Kreisl, T. N.; Kim, L.; Duic, J. P.; Butman, J. A.; Albert, P. S.; Fine, H. A. (2010). "Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas". Cancer. 116 (7): NA. doi:10.1002/cncr.24957. PMC 2846997 Freely accessible. PMID 20143438.
- ↑ Pascuzzi, R. M.; Shefner, J.; Chappell, A. S.; Bjerke, J. S.; Tamura, R.; Chaudhry, V.; Clawson, L.; Haas, L.; Rothstein, J. D. (2009). "A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis". Amyotrophic Lateral Sclerosis. 11 (3): 091207182741053. doi:10.3109/17482960903307805. PMID 19961264.
- ↑ Aujla, P. K.; Fetell, M. R.; Jensen, F. E. (2009). "Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model". Epilepsia. 50 (4): 694. doi:10.1111/j.1528-1167.2008.01947.x. PMC 2672962 Freely accessible. PMID 19220413.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- AMPA receptor modulators
- Anticonvulsants
- Antineoplastic drugs
- Dioxolobenzodiazepines
- Antineoplastic and immunomodulating drug stubs
- Anticonvulsant stubs